Neuroquant is an FDA approved tool for accurate brain volume assessment, typically run on a T1 volumetric MRI brain imaging profile.
A 3D T1 Saggital MP-RAGE protocol sequence is required to run the imaging report. NeuroQuant is preferred by Dr Shoemaker in his work reporting on atrophy and oedema changes in the brain relating to biotoxin exposure.
See sample report for further details.
References
Ross DE, Ochs AL, Seabaugh JM, Shrader CR; Alzheimer's Disease Neuroimaging Initiative. Man versus machine: comparison of radiologist interpretations and NeuroQuant® volumetric analyses of brain MRIs in patients with traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2013;25(1):32- 39. doi:10.1176/appi.neuropsych.11120377
McMahon, SW, MD, Shoemaker RC, MD, Ryan JC PhD, Reduction in Forebrain Parenchymal and Cortical Grey Matter Swelling across Treatment Groups in Patients with Inflammatory Illness Acquired Following Exposure to Water-Damaged Building. J Neurosci Clin Res Vol, Issue 1